Inhaleret nitrogenoxid til kritisk syge patienter

Translated title of the contribution: [Nitrogen oxide inhalation in critically ill patients]

J Bonde, K Antonsen, S W Henneberg, B Uhrbrandt, M C Wanscher

Abstract

Inhaled nitric oxide (iNO) has been extensively used in the treatment of severe hypoxaemic respiratory failure and/or pulmonary hypertension. Although the majority of studies have almost consistently demonstrated a beneficial effect on oxygenation and a reduction in pulmonary artery pressures, none of the randomised trials have reported a reduced mortality using iNO on patients with severe respiratory failure. In neonates with severe respiratory failure and pulmonary hypertension, however, iNO can reduce the need of extracorporal membrane oxygenation. Prior to using iNO on adult patients we suggest other measures to be taken (i.e. optimising ventilator settings, ventilation in prone position).
Translated title of the contribution[Nitrogen oxide inhalation in critically ill patients]
Original languageDanish
JournalUgeskrift for Laeger
Volume162
Issue number3
Pages (from-to)335-9
Number of pages5
ISSN0041-5782
Publication statusPublished - 17 Jan 2000

Fingerprint

Dive into the research topics of '[Nitrogen oxide inhalation in critically ill patients]'. Together they form a unique fingerprint.

Cite this